TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: 3.60E+3nMAssay Description:Inhibition of PTPRBMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: 6.00E+3nMAssay Description:Inhibition of PTPRBMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: 1.10E+4nMAssay Description:Inhibition of PTPRBMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: 1.40E+4nMAssay Description:Inhibition of PTPRBMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: 1.70E+4nMAssay Description:Inhibition of PTPRBMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: 1.80E+4nMAssay Description:Inhibition of PTPRBMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: 1.90E+4nMAssay Description:Inhibition of PTPRBMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: 2.10E+4nMAssay Description:Inhibition of PTPRBMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: 2.60E+4nMAssay Description:Noncompetitive inhibition of human GST-tagged LMW-PTP-B expressed in Escherichia coli JM 109 cells using p-nitrophenyl phosphate as substrate after 1...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: 3.30E+4nMAssay Description:Inhibition of PTPRBMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: 7.32E+4nMAssay Description:Noncompetitive inhibition of human GST-tagged LMW-PTP-B expressed in Escherichia coli JM 109 cells using p-nitrophenyl phosphate as substrate after 1...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: >1.00E+5nMAssay Description:Inhibition of human PtpBMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: 1.60E+5nMAssay Description:Inhibition of PTPRBMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataKi: 5.60E+5nMAssay Description:Inhibition of PTPRBMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.0100nMAssay Description:Non-limiting examples of the HPTPβ IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.0100nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.0100nMAssay Description:Non-limiting examples of the HPTP-β IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.0800nMAssay Description:Non-limiting examples of the HPTP-β IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.0800nMAssay Description:Non-limiting examples of the HPTPβ IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.0800nMAssay Description:Non-limiting examples of the HPTPβ IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.0800nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.0800nMAssay Description:Non-limiting examples of the HPTP-β IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.0800nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.0900nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.0900nMAssay Description:Non-limiting examples of the HPTPβ IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.0900nMAssay Description:Non-limiting examples of the HPTP-β IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Non-limiting examples of the HPTPβ IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Non-limiting examples of the HPTPβ IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Non-limiting examples of the HPTPβ IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Non-limiting examples of the HPTP-β IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Non-limiting examples of the HPTP-β IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Non-limiting examples of the HPTP-β IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.140nMAssay Description:Non-limiting examples of the HPTP-β IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.140nMAssay Description:Non-limiting examples of the HPTPβ IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.140nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.157nMAssay Description:Non-limiting examples of the HPTP-β IC50 (μM) activity.More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
Astex Therapeutics Ltd.
Curated by ChEMBL
Astex Therapeutics Ltd.
Curated by ChEMBL
Affinity DataIC50: 0.157nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N...More data for this Ligand-Target Pair